21.
Broad phylogenomic sampling improves resolution of the animal tree of life
by Dunn, Casey W
Nature (London), 2008-04-10, Vol.452 (7188), p.745-749

22.
Absence of BRAF mutations in UV-protected mucosal melanomas
by Edwards, R H
Journal of medical genetics, 2004-04, Vol.41 (4), p.270-272

23.
Classification of deadlift biomechanics with wearable inertial measurement units
by O'Reilly, Martin A
Journal of biomechanics, 2017, Vol.58, p.155-161

24.
Bilateral vestibular schwannomas in older patients: NF2 or chance?
by Evans, D G
Journal of medical genetics, 2015-06, Vol.52 (6), p.422-424

25.
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome
by Slade, Ingrid
Journal of medical genetics, 2011-04, Vol.48 (4), p.273-278

26.
Allan-Herndon-Dudley Syndrome and the Monocarboxylate Transporter 8 ( MCT8) Gene
by Schwartz, Charles E
American journal of human genetics, 2005, Vol.77 (1), p.41-53

27.
Predicting Out-of-Office Blood Pressure in the Clinic (PROOF-BP): Derivation and Validation of a Tool to Improve the Accuracy of Blood Pressure Measurement in Clinical Practice
by Sheppard, James P
Hypertension (Dallas, Tex. 1979), 2016-05, Vol.67 (5), p.941-950

28.

29.
MICA, a gene contributing strong susceptibility to ankylosing spondylitis
by Zhou, Xiaodong
Annals of the Rheumatic Diseases, 2014-08, Vol.73 (8), p.1552-1557

30.
Consensus on Exercise Reporting Template (CERT): Modified Delphi Study
by Slade, S.C
Physical therapy, 2016, Vol.96 (10), p.1514-1524

31.
Refinement of a 400-kb Critical Region Allows Genotypic Differentiation between Isolated Lissencephaly, Miller-Dieker Syndrome, and Other Phenotypes Secondary to Deletions of 17p13...
by Cardoso, Carlos
American journal of human genetics, 2003-04, Vol.72 (4), p.918-930

32.
Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis
by Rossi, Adriano G
Nature medicine, 2006-09, Vol.12 (9), p.1056-1064

33.

34.
Utility of overnight pulse oximetry and heart rate variability analysis to screen for sleep-disordered breathing in chronic heart failure
by Ward, Neil R
Thorax, 2012-11, Vol.67 (11), p.1000-1005

35.
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
by Lane, J Athene, PhD
The lancet oncology, 2014, Vol.15 (10), p.1109-1118

36.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised,...
by Sax, Paul E, Dr Prof
The Lancet (British edition), 2015, Vol.385 (9987), p.2606-2615

37.
The Choice of Normative Pediatric Reference Database Changes Spine Bone Mineral Density Z-Scores But Not the Relationship Between Bone Mineral Density and Prevalent Vertebral Fract...
by Ma, Jinhui
The journal of clinical endocrinology and metabolism, 2015-03, Vol.100 (3), p.1018-1027

38.
Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC)
by Weiss, Anna
Annals of surgical oncology, 2019-10-17, Vol.26 (13), p.4364-4371

39.
Possibilities and limitations of the polar RS800 in measuring heart rate variability at rest
by Wallén, Martin Benka
European journal of applied physiology, 2011-07-16, Vol.112 (3), p.1153-1165

40.
The Cost‐Effectiveness of Different Management Strategies for Patients on Chronic Warfarin Therapy
by Lafata, Jennifer Elston
Journal of general internal medicine, 2000-01, Vol.15 (1), p.31-37
